Earnings History Data for Eton Pharmaceuticals, Inc. (ETON) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | AH | ETON | Eton Pharmaceuticals, Inc. | 226.84 | 0.02 | -0.01 | -0.02 | Eton Pharmaceuticals GAAP EPS of $0.02 beats by $0.03, revenue of $10.3M beats by $0.6M [11/12/2024 4:20 PM] |
10.43 | 1.26 (13.74%) |
9.90 | 0.73 (7.96%) |
3.03 - 11.11 | 624,203 | 190,000 | 4,339 | ||
| 08-08-2024 | AH | ETON | Eton Pharmaceuticals, Inc. | 89.92 | -0.12 | 0.00 | 0.18 | Eton Pharmaceuticals GAAP EPS of -$0.12 misses by $0.05, revenue of $9.07M beats by $0.27M [8/8/2024 4:11 PM] |
3.70 | 0.08 (2.21%) |
3.53 | -0.09 (-2.49%) |
2.47 - 5.81 | 188,317 | 60,000 | 11,256 | ||
| 09-05-2024 | AH | ETON | Eton Pharmaceuticals, Inc. | 95.56 | -0.03 | 0.00 | -0.10 | Eton Pharmaceuticals GAAP EPS of -$0.03, revenue of $8M [5/9/2024 4:42 PM] |
3.42 | -0.02 (-0.44%) |
3.60 | 0.17 (4.80%) |
2.42 - 5.81 | 136,406 | 60,000 | 5,379 | ||
| 14-03-2024 | AH | ETON | Eton Pharmaceuticals, Inc. | 112.90 | -0.09 | -0.04 | 0.04 | Eton Pharmaceuticals GAAP EPS of -$0.09 misses by $0.05, revenue of $7.3M misses by $0.36M [3/14/2024 4:10 PM] |
3.85 | -0.61 (-13.67%) |
4.20 | -0.26 (-5.83%) |
2.42 - 5.81 | 184,534 | 60,000 | 3,641 | ||
| 09-11-2023 | AH | ETON | Eton Pharmaceuticals, Inc. | 114.67 | -0.02 | -0.10 | -0.12 | Eton Pharmaceuticals GAAP EPS of -$0.02, revenue of $7M [11/9/2023 4:14 PM] |
3.84 | -0.69 (-15.16%) |
4.55 | 0.02 (0.44%) |
2.40 - 5.81 | 200,224 | 70,000 | 884 | ||
| 10-08-2023 | AH | ETON | Eton Pharmaceuticals, Inc. | 66.57 | 0.18 | -0.09 | -0.06 | Eton Pharmaceuticals GAAP EPS of $0.18, revenue of $12M [8/10/2023 4:42 PM] |
3.57 | 0.97 (37.31%) |
3.41 | 0.81 (31.15%) |
1.95 - 4.28 | 9,888,790 | 60,000 | 5,394,280 | ||
| 11-05-2023 | AH | 4:05 PM ET (May 11) |
ETON | Eton Pharmaceuticals, Inc. | 92.84 | -0.10 | -0.14 | -0.21 | Eton Pharmaceuticals GAAP EPS of -$0.10 beats by $0.04, revenue of $5.3M beats by $0.74M [5/11/2023 4:04 PM] |
3.58 | 0.10 (3.03%) |
3.56 | 0.09 (2.59%) |
1.95 - 4.25 | 45,238 | 40,000 | 4,463 | |
| 16-03-2023 | AH | 4:05 PM ET (Mar 16) |
ETON | Eton Pharmaceuticals, Inc. | 94.36 | 0.04 | 0.01 | 0.04 | Eton Pharmaceuticals GAAP EPS of $0.04 beats by $0.03, revenue of $8.5M misses by $0.62M [3/16/2023 4:10 PM] |
3.90 | -0.20 (-4.88%) |
4.00 | -0.10 (-2.44%) |
1.95 - 4.50 | 163,240 | 60,000 | 284 | |
| 10-11-2022 | AH | 4:00 PM ET (Nov 10) |
ETON | Eton Pharmaceuticals, Inc. | 65.77 | -0.12 | -0.15 | -0.24 | Eton Pharmaceuticals GAAP EPS of -$0.12, revenue of $3.22M [11/10/2022 4:24 PM] |
2.97 | 0.46 (18.33%) |
2.79 | 0.28 (11.16%) |
1.95 - 5.23 | 237,649 | 90,000 | 138 | |
| 11-08-2022 | AH | 4:00 PM ET (Aug 11) |
ETON | Eton Pharmaceuticals, Inc. | 68.61 | -0.06 | 0.03 | -0.08 | Eton Pharmaceuticals GAAP EPS of -$0.06 misses by $0.09, revenue of $7.4M misses by $0.36M [8/11/2022 4:03 PM] |
2.97 | -0.04 (-1.33%) |
2.75 | -0.26 (-8.64%) |
2.47 - 6.72 | 206,730 | 60,000 | 100 | |
| 12-05-2022 | AH | 4:00 PM ET (May 12) |
ETON | Eton Pharmaceuticals, Inc. | 77.57 | -0.21 | -0.08 | 0.19 | Eton Pharmaceuticals GAAP EPS of -$0.21, revenue of $2.18M [5/12/2022 4:21 PM] |
3.24 | 0.35 (12.11%) |
2.92 | 0.03 (1.04%) |
2.76 - 8.90 | 153,715 | 60,000 | 2,106 | |
|
||||||||||||||||||
| 16-03-2022 | AH | 4:05 PM ET (Mar 16) |
ETON | Eton Pharmaceuticals, Inc. | 94.73 | 0.04 | 0.05 | -0.32 | Eton Pharmaceuticals GAAP EPS of $0.04 misses by $0.01, revenue of $6.09M misses by $1.47M [3/16/2022 4:06 PM] |
4.18 | 0.25 (6.36%) |
4.07 | 0.14 (3.56%) |
3.01 - 8.90 | 266,919 | 151,180 | 6,944 | |
| 15-11-2021 | AH | 4:00 PM ET (Nov 15) |
ETON | Eton Pharmaceuticals, Inc. | 119.80 | -0.24 | -0.14 | -0.31 | Eton Pharmaceuticals EPS misses by $0.10, misses on revenue [11/15/2021 4:17 PM] |
4.84 | -0.27 (-5.28%) |
4.55 | -0.56 (-10.96%) |
4.03 - 10.30 | 581,054 | 900,000 | 13,820 | |
|
||||||||||||||||||
| 16-08-2021 | AH | 4:05 PM ET (Aug 16) |
ETON | Eton Pharmaceuticals, Inc. | 143.86 | -0.08 | -0.14 | -0.23 | Eton Pharmaceuticals EPS beats by $0.06, misses on revenue [8/16/2021 4:11 PM] |
4.19 | -0.05 (-1.18%) |
4.24 | 0.0 (0.00%) |
4.03 - 10.30 | 499,238 | 1,210,000 | 9,796 | |
|
||||||||||||||||||
| 13-05-2021 | AH | 4:00 PM ET (May 13) |
ETON | Eton Pharmaceuticals, Inc. | 193.66 | 0.19 | 0.19 | -0.50 | Eton Pharmaceuticals EPS in-line, misses on revenue [5/13/2021 4:25 PM] |
8.23 | 0.50 (6.47%) |
8.00 | 0.27 (3.49%) |
4.33 - 10.30 | 426,341 | 250,000 | 1,809 | |
| 16-03-2021 | AH | 4:05 PM ET (Mar 16) |
ETON | Eton Pharmaceuticals, Inc. | 198.79 | -0.32 | -0.27 | -0.15 | Eton Pharmaceuticals EPS misses by $0.06, misses on revenue [3/16/2021 4:21 PM] |
8.02 | 0.10 (1.26%) |
7.80 | 0.02 (0.26%) |
2.50 - 10.30 | 202,301 | 201,046 | 0 | |
|
||||||||||||||||||
| 12-11-2020 | AH | ETON | Eton Pharmaceuticals, Inc. | 165.82 | -0.31 | -0.26 | -0.28 | Eton Pharmaceuticals EPS misses by $0.06 [11/12/2020 4:24 PM] |
7.18 | -0.06 (-2.84%) |
7.35 | -0.04 (-0.54%) |
2.50 - 9.12 | 265,389 | 249,641 | 14,251 | ||
|
|
||||||||||||||||||
| 12-08-2020 | PM | ETON | Eton Pharmaceuticals, Inc. | 164.09 | -0.23 | -0.28 | -0.18 | Eton Pharmaceuticals EPS beats by $0.03, misses on revenue [8/12/2020 8:32 AM] |
6.72 | 0.34 (5.41%) |
6.18 | -0.20 (-3.06%) |
2.50 - 8.74 | 222,574 | 841,367 | 8,695 | ||
|
|
||||||||||||||||||
| 14-05-2020 | AH | ETON | Eton Pharmaceuticals, Inc. | 113.29 | -0.50 | -0.24 | -0.42 | Eton Pharmaceuticals EPS misses by $0.28, misses on revenue [5/14/2020 4:17 PM] |
4.75 | -0.45 (-8.65%) |
4.85 | 0.25 (5.43%) |
2.50 - 9.07 | 158,056 | 65,387 | 0 | ||
|
|
||||||||||||||||||